Literature DB >> 11330825

The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy.

A J van Wamel1, C Ruwhof, L E van der Valk-Kokshoom, P I Schrier, A van der Laarse.   

Abstract

Cardiac hypertrophy is a compensatory response of myocardial tissue upon increased mechanical load. Of the mechanical factors, stretch is rapidly followed by hypertrophic responses. We tried to elucidate the role of angiotensin II (AII), endothelin-1 (ET-1) and transforming growth factor-beta (TGF-beta) as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy. We collected conditioned medium (CM) from stretched cardiomyocytes and from other stretched cardiac cells, such as cardiac fibroblasts, endothelial cells and vascular smooth muscle cells (VSMCs). These CMs were administered to stationary cardiomyocytes with or without an AII type 1 (AT1) receptor antagonist (losartan), an ET-1 type A (ET(A)) receptor antagonist (BQ610), or anti-TGF-beta antibodies. By measuring the mRNA levels of the proto-oncogene c-fos and the hypertrophy marker gene atrial natriuretic peptide (ANP), the molecular phenotype of the CM-treated stationary cardiomyocytes was characterized. Our results showed that c-fos and ANP expression in stationary cardiomyocytes was increased by All release from cardiomyocytes that had been stretched for 60 min. Stretched cardiomyocytes, cardiac fibroblasts and endothelial cells released ET-1 which led to increased c-fos and ANP expression in stationary cardiomyocytes. ET-1 released by stretched VSMCs, and TGF-beta released by stretched cardiac fibroblasts and endothelial cells, appeared to be paracrine mediators of ANP expression in stationary cardiomyocytes. These results indicate that AII, ET-1 and TGF-beta (released by cardiac and vascular cell types) act as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy. Therefore, it is likely that in stretched myocardium the cardiomyocytes, cardiac fibroblasts, endothelial cells and VSMCs take part in intercellular interactions contributing to cardiomyocyte hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330825     DOI: 10.1023/a:1007279700705

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts.

Authors:  C Ruwhof; A E van Wamel; J M Egas; A van der Laarse
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Endothelin-1 induces expression of fetal genes through the interleukin-6 family of cytokines in cardiac myocytes.

Authors:  S Saito; R Aikawa; I Shiojima; R Nagai; Y Yazaki; I Komuro
Journal:  FEBS Lett       Date:  1999-07-30       Impact factor: 4.124

3.  Stretching cardiac myocytes stimulates protooncogene expression.

Authors:  I Komuro; T Kaida; Y Shibazaki; M Kurabayashi; Y Katoh; E Hoh; F Takaku; Y Yazaki
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

4.  Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; Y Hiroi; T Mizuno; K Maemura; H Kurihara; R Aikawa; H Takano; Y Yazaki
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

5.  Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

Authors:  L Cao; D G Gardner
Journal:  Hypertension       Date:  1995-02       Impact factor: 10.190

6.  Role of cardiac nonmyocytes in cyclic mechanical stretch-induced myocyte hypertrophy.

Authors:  M Harada; Y Saito; O Nakagawa; Y Miyamoto; M Ishikawa; K Kuwahara; E Ogawa; M Nakayama; S Kamitani; I Hamanaka; N Kajiyama; I Masuda; H Itoh; I Tanaka; K Nakao
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

Review 7.  Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.

Authors:  D E Dostal; R A Hunt; C E Kule; G J Bhat; V Karoor; C D McWhinney; K M Baker
Journal:  J Mol Cell Cardiol       Date:  1997-11       Impact factor: 5.000

8.  Endothelin acts as a paracrine regulator of stretch-induced atrial natriuretic peptide release.

Authors:  J P Skvorak; S J Nazian; J R Dietz
Journal:  Am J Physiol       Date:  1995-11

9.  Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts.

Authors:  N N Kim; F J Villarreal; M P Printz; A A Lee; W H Dillmann
Journal:  Am J Physiol       Date:  1995-09

Review 10.  Molecular biology of myocardial hypertrophy and failure: gene expression and trophic signaling.

Authors:  T G Parker
Journal:  New Horiz       Date:  1995-05
View more
  34 in total

1.  Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.

Authors:  Eric K Chu; Jason Cheng; John S Foley; Brigham H Mecham; Caroline A Owen; Kathleen J Haley; Thomas J Mariani; Isaac S Kohane; Daniel J Tschumperlin; Jeffrey M Drazen
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

Review 2.  Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.

Authors:  Joshua Mayourian; Delaine K Ceholski; David M Gonzalez; Timothy J Cashman; Susmita Sahoo; Roger J Hajjar; Kevin D Costa
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

3.  Inhibitory effect of trilinolein on endothelin-1-induced c-fos gene expression in cultured neonatal rat cardiomyocytes.

Authors:  Hung-Yu Yang; Ju-Chi Liu; Yen-Ling Chen; Cheng-Hsien Chen; Heng Lin; Jia-Wei Lin; Wen-Ta Chiu; Jin-Jer Chen; Tzu-Hurng Cheng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-22       Impact factor: 3.000

4.  Cardiomyocyte d-dopachrome tautomerase protects against heart failure.

Authors:  Yina Ma; Kevin N Su; Daniel Pfau; Veena S Rao; Xiaohong Wu; Xiaoyue Hu; Lin Leng; Xin Du; Marta Piecychna; Kenneth Bedi; Stuart G Campbell; Anne Eichmann; Jeffrey M Testani; Kenneth B Margulies; Richard Bucala; Lawrence H Young
Journal:  JCI Insight       Date:  2019-09-05

Review 5.  Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.

Authors:  Jay D Humphrey; Martin A Schwartz; George Tellides; Dianna M Milewicz
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

6.  Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

Authors:  Polakit Teekakirikul; Seda Eminaga; Okan Toka; Ronny Alcalai; Libin Wang; Hiroko Wakimoto; Matthew Nayor; Tetsuo Konno; Joshua M Gorham; Cordula M Wolf; Jae B Kim; Joachim P Schmitt; Jefferey D Molkentin; Russell A Norris; Andrew M Tager; Stanley R Hoffman; Roger R Markwald; Christine E Seidman; Jonathan G Seidman
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 7.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

8.  Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy.

Authors:  Tzu-Hurng Cheng; Ju-Chi Liu; Heng Lin; Neng-Lang Shih; Yen-Ling Chen; Meng-Ting Huang; Paul Chan; Ching-Feng Cheng; Jin-Jer Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-09       Impact factor: 3.000

9.  Thyroid Hormone Increases TGF-beta1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors.

Authors:  Gabriela Placoná Diniz; Marcela Sorelli Carneiro-Ramos; Maria Luiza Morais Barreto-Chaves
Journal:  Int J Endocrinol       Date:  2010-06-02       Impact factor: 3.257

10.  Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.

Authors:  Kalyani D Panse; Leanne E Felkin; Marina M López-Olañeta; Jesús Gómez-Salinero; María Villalba; Lucía Muñoz; Kazuto Nakamura; Masayuki Shimano; Kenneth Walsh; Paul J R Barton; Nadia Rosenthal; Enrique Lara-Pezzi
Journal:  J Cardiovasc Transl Res       Date:  2012-08-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.